UMaine biotech start-up Neuright to be featured in March 15 Innovation Blender

Kristy Townsend, University of Maine alumna and former faculty member, and cofounder of Neuright Inc., will lead a discussion, “Neuright Inc. Tackles Peripheral Neuropathy — Catch It Early, Fix It Fast,” as part of the Innovation Blender series sponsored by MaineHealth Innovation and The Roux Institute.

Neuright is a UMaine biotech start-up and academic spin-out company that has commercialized a new patent-pending theragnostic medical device for peripheral neuropathy, a condition of nerve death in tissues and organs that is common with aging, diabetes, and more than 30 other diseases and disorders. Read more

Related Posts

UMaine professor McGill receives top German research award

ORONO — University of Maine ecology professor Brian McGill was awarded the Humboldt Research Award, one of the most prestigious scientific...

20 July 2023

Four Maine workforce programs could get $6.5M in fed funding

Four workforce training programs in Maine could receive nearly $6.5 million in federal funding through the markup of the fiscal year 2024 financial...

18 July 2023

Music as medicine: FDA approves stroke damage therapy from Portland startup

Doctors may soon start writing an unconventional prescription to help stroke survivors regain their ability to walk: music. MedRhythms, a Portland...

14 July 2023